Table 5.
Variable | Asthmatic (n=30) | Non-Asthmatic (n=32) | χ2 | P-value | |||
---|---|---|---|---|---|---|---|
|
|
||||||
N | % | N | % | ||||
Chest X ray (CXR) | Abnormal CXR | 11 | 36.7% | 12 | 37.5% | 0.005 | 0.946† |
Focal opacities | 4 | 13.3% | 3 | 9.4% | - | 0.703‡ | |
Patchy opacities | 2 | 6.7% | 4 | 12.5% | - | 0.672‡ | |
Bronchopneumonia/Interstitial infiltration | 5 | 16.7% | 4 | 12.5% | - | 0.728‡ | |
Effusion | 0 | 0.0% | 1 | 3.1% | - | >0.999‡ | |
COVID-19 reporting and data system (CO-RAD) classification | Total tests (n=10) | Total tests (n=16) | |||||
CO-RADS 1 | 0 | 0.0% | 4 | 25.0% | 9.344 | 0.002§ | |
CO-RADS 2 | 1 | 10.0% | 5 | 31.3% | |||
CO-RADS 3 | 0 | 0.0% | 1 | 6.3% | |||
CO-RADS 4 | 2 | 20.0% | 5 | 31.3% | |||
CO-RADS 5 | 7 | 70.0% | 1 | 6.3% | |||
Echocardiography | Total tests (n=8) | Total tests (n=3) | |||||
Pericardial effusion | 1 | 12.5% | 2 | 66.7% | - | 0.152‡ |
χ2=chi-squared test;
Pearson chi-squared test;
Fisher’s exact test;
Chi-squared test for trend.